Jesse Joachim Swen

61PUBLICATIONS
172CO-AUTHORS
Predictive and prognostic markersPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Nanotoxicology, health and safetyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (61)

|Sep 11, 2026
Development of a dosing algorithm integrating pharmacogenetic markers and inflammation for individualization of initial voriconazole maintenance doses.

|Jul 13, 2026
Design characteristics of mass balance studies conducted for protein kinase inhibitors.

|Jun 08, 2026
Pharmacokinetics of 5-Fluorouracil in Patients Treated With Capecitabine Carrying the c.1236G>A DPYD Variant Allele.

|May 28, 2026
From evidence to implementation: key priorities for pharmacogenomics-guided treatment and prevention from a European expert workshop.

|Mar 02, 2026
Inflammation-driven variability in drug metabolism: Insights from voriconazole treatment of HSCT recipients.

Sylvia D Klomp, Martijn L Manson, Henk-Jan Guchelaar

|Jan 12, 2026
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and CYP2C19 and tricyclic antidepressants.

Kristian Kleine Schaars, Marga Nijenhuis, Bianca Soree

Pageof 11

Frequent Collaborators

21 joint publications

Henk-Jan Guchelaar

11 joint publications

Marga Nijenhuis

11 joint publications

Elisa J F Houwink

9 joint publications

Roos van Westrhenen